These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6408755)

  • 21. Angiogenic activity of fibrin degradation products is located in fibrin fragment E.
    Thompson WD; Smith EB; Stirk CM; Marshall FI; Stout AJ; Kocchar A
    J Pathol; 1992 Sep; 168(1):47-53. PubMed ID: 1280677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
    Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L
    Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Binding of K 1-3 and K 4 fragments of plasminogen containing lysine-binding sites with fibrinogen and its fragments].
    Tret'iachenko VG; Grinenko TV; Kudinov SA
    Ukr Biokhim Zh (1978); 1988; 60(2):3-6. PubMed ID: 3394172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
    Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
    Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium binding to human fibrinogen - localization of two calcium specific sites.
    Lindsey GG; Brown G; Purves LR
    Thromb Res; 1978 Sep; 13(3):345-50. PubMed ID: 741431
    [No Abstract]   [Full Text] [Related]  

  • 27. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proteolytic activity of the Glu-plasminogen complex with fibrinogen fragment E].
    Skomorovskaia EV; Grinenko TV; Kudinov SA; Zolotareva EN
    Biokhimiia; 1991 Mar; 56(3):458-66. PubMed ID: 1883906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of ligand-ligand interactions in competition by fibrinogen and fibrin degradation products for fibrinogen binding to human platelets.
    Pasqua JJ; Pizzo SV
    Biochim Biophys Acta; 1983 Jun; 757(3):282-7. PubMed ID: 6849976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen.
    Horwitz BH; Váradi A; Scheraga HA
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):5980-4. PubMed ID: 6592597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of tissue-type plasminogen activator to fibrinogen fragments.
    Bosma PJ; Rijken DC; Nieuwenhuizen W
    Eur J Biochem; 1988 Mar; 172(2):399-404. PubMed ID: 3127207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
    Doolittle RF; Spraggon G; Everse SJ
    Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
    [No Abstract]   [Full Text] [Related]  

  • 34. Factor XIII binds to the A alpha- and B beta- chains in the D-domain of fibrinogen: an immunoblotting study.
    Mary A; Achyuthan KE; Greenberg CS
    Biochem Biophys Res Commun; 1987 Sep; 147(2):608-14. PubMed ID: 2958007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
    Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
    Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X).
    Nieuwenhuizen W; Gravesen M
    Biochim Biophys Acta; 1981 Mar; 668(1):81-8. PubMed ID: 6453618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the fragment D-fibrin monomer complex formation by salting-out fractionation].
    Pozdniakova TM; Rybachuk VN; Vovk Ev
    Biokhimiia; 1982 Jun; 47(6):971-6. PubMed ID: 7115809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biologically active low-molecular fragments of fibrinogen molecule].
    Musialkivs'ka AO; Platonova TM; Radavs'kiĭ IuL
    Ukr Biokhim Zh; 1977; 49(3):89-93. PubMed ID: 888231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of fibrin-platelet interactions by fibrinogen-degradation fragment D.
    Orloff KG; Michaeli D
    Am J Physiol; 1977 Aug; 233(2):H305-11. PubMed ID: 888974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.